ABBOTT LABORATORIES — Director's Dealing 2014

Feb 25, 2014

Page 1 of 1

SEC FORM 4

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

OMB APPROVAL

Washington, D.C. 20549

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB Number: 3235-0287 December 31, Expires: 2014

Estimated average burden hours per 0.5 response:

1. Name and Address of Reporting Person* Landgraf John C (Last) (First) (Middle) 100 ABBOTT PARK ROAD (Street) ABBOTT PARK IL 60064-6400 (City) (State) (Zip)

2. Issuer NameandTicker or Trading Symbol ABBOTT LABORATORIES[ABT] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director 10% Owner X Officer (give title below) Other (specify below) Executive Vice President 3. Date of Earliest Transaction (Month/Day/Year) 02/21/2014 4. If Amendment, Date of Original Filed (Month/Day/Year) 6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned

1. Title of Security (Instr. 3)	2. Transaction Date	2A. Deemed Execution Date,	3. Transaction	3. Transaction	4. Securities Disposed Of	Acquired (D) (Instr.	(A) or 3, 4 and	5. Amount of Securities	6. Ownership Form: Direct	7. Nature of Indirect
	(Month/Day/Year)	if any	Code	(Instr.	5)			Beneficially	(D) or Indirect	Beneficial
		(Month/Day/Year)	8)					Owned Following	(I) (Instr. 4)	Ownership
								Reported		(Instr. 4)
			Code	V	Amount	(A) or (D)	Price	Transaction(s) (Instr. 3 and 4)
Common shares without par value	02/21/2014		A		25,310 (1)	A	$0	127,731	D
										Profit
Common shares without par value								18,570 (2)	I	Sharing
										Trust
Common shares without par value								167 (3)	I	By self for son

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)

1. Title of	2.	3. Transaction	3A. Deemed	4.		5. Number	of	6. Date Exercisable and	6. Date Exercisable and	7. Title and	Amount of	8. Price of	9. Number	10.	11. Nature
Derivative	Conversion	Date	Execution Date,	Transaction		Derivative		Expiration Date		Securities Underlying		Derivative	of	Ownership	of Indirect
Security (Instr. 3)	or Exercise	(Month/Day/Year)	if any	Code	(Instr.	Securities		(Month/Day/Year)		Derivative Security		Security	derivative	Form:	Beneficial
	Price of		(Month/Day/Year)	8)		Acquired (A)				(Instr. 3 and 4)		(Instr. 5)	Securities	Direct (D)	Ownership
	Derivative					or Disposed							Beneficially	or Indirect	(Instr. 4)
	Security					of (D) (Instr. 3,							Owned	(I) (Instr. 4)
						4 and 5)							Following
													Reported
											Amount or		Transaction
								Date	Expiration		Number of		(s) (Instr. 4)
				Code	V	(A)	(D)	Exercisable	Date	Title	Shares
Option (right to buy) (4)	$39.12	02/21/2014		A		154,953		02/21/2015	02/20/2024	Common Shares	154,953	$0	154,953	D

Explanation of Responses:

1. These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes.

2. Balance in the Abbott Laboratories Stock Retirement Trust as of February 21, 2014.

3. The reporting person disclaims beneficial ownership of all securities held by his son.

4. Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 51,651 on 2/21/2015, 51,651 on 2/21/2016, and 51,651 on 2/21/2017.

John A. Berry, by power of 02/25/2014 attorney for John C. Landgraf ** Signature of Reporting Person Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

• If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

• ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

2/25/2014